Pharma in Brief aims to provide timely updates on legal and regulatory developments affecting the pharmaceutical industry. We focus on the key issues that matter to you, and keep you informed in a concise and easy to read format.

Pharma in brief is written by Norton Rose Fulbright litigation and regulatory lawyers, with expertise in all areas of the pharmaceutical industry, including  patent and class action disputes,  data protection, patent-term restoration, biologics, drug advertising, drug reimbursement, pricing and price regulation, and compliance with Health Canada’s governing laws and guidelines.

About the Pharmaceuticals and life sciences team

Our global pharmaceuticals and life sciences team provides a range of innovative pharmaceutical, biotechnology, and medical device companies with market-leading legal knowledge and a highly commercial approach to doing business in this dynamic sector. With capabilities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia, we can provide integrated advice on both domestic and cross-border matters for our pharmaceutical and technology clients.

Our clients include innovative pharmaceutical companies, bioscience and biotechnology companies, medical device manufacturers and food technology companies and their investors, including venture capital and private equity firms. Many of our lawyers have scientific backgrounds and a deep industry focus, enabling us to advise on all aspects of the pharmaceutical life cycle – from innovation, development, commercialisation and exploitation, through to contentious proceedings before the courts and regulatory authorities.

Our areas of work include

  • international IP litigation
  • product liability
  • IP strategies
  • M&A
  • fund raising and investment
  • antitrust
  • regulatory and compliance
  • labour and employment
  • tax
  • government investigations.

About Norton Rose Fulbright

Norton Rose Fulbright is a global law firm. We provide the world’s pre-eminent corporations and financial institutions with a full business law service. We have more than 3000 lawyers based in over 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia. Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity.

Recognised for our industry focus, we are strong across the key industry sectors: financial institutions; energy, infrastructure and resources; transport; technology; life sciences and healthcare; and consumer markets.

Norton Rose Fulbright US LLP, Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP and Norton Rose Fulbright South Africa Inc are separate legal entities and all of them are members of Norton Rose Fulbright Verein, a Swiss verein. Norton Rose Fulbright Verein helps coordinate the activities of the members but does not itself provide legal services to clients.

Stay connected and subscribe to the blog today.